Denali Therapeutics (DNLI) EBT Margin (2018 - 2026)
Denali Therapeutics' EBT Margin came in at -696.78% for Q3 2026, up 2842.42 percentage points from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) EBT Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Denali Therapeutics reported EBT Margin of -2377.33%; for FY2023, it was -43.93%, up 256.61 percentage points from FY2022.
- EBT Margin carries a five-year change of -15.87 percentage points (FY2018 to FY2023).
- Going back by year, EBT Margin was -300.54% in FY2022 (+297.80 pp), -598.34% in FY2021 (-619.77 pp), 21.44% in FY2020 (+763.49 pp) and -742.05% in FY2019 (-714.00 pp).
- The Q3 2026 figure represents the highest quarterly EBT Margin since Q2 2023.
- The fastest year-over-year change in EBT Margin over five years came in Q1 2022 (a gain of 726.22 percentage points), and the weakest in Q3 2023 (a drop of 4939.12 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Denali Therapeutics | 3.83 Bn | 743.92 Mn | 17.59 Mn | -696.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -696.78% |
| Jun 30, 2026 | -3,539.21% |
| Sep 30, 2023 | -7,841.59% |
| Jun 30, 2023 | 62.35% |
| Mar 31, 2023 | -312.40% |
| Dec 31, 2022 | -959.68% |
| Sep 30, 2022 | -2,902.47% |
| Jun 30, 2022 | -111.98% |
| Mar 31, 2022 | -157.80% |
| Dec 31, 2021 | -606.01% |
| Sep 30, 2021 | -1,600.53% |
| Jun 30, 2021 | -264.58% |
| Mar 31, 2021 | -884.02% |
| Dec 31, 2020 | 77.56% |
| Sep 30, 2020 | -619.31% |
| Jun 30, 2020 | -1,003.57% |
| Mar 31, 2020 | -1,578.75% |
| Dec 31, 2019 | -1,154.75% |
| Sep 30, 2019 | -340.88% |
| Jun 30, 2019 | -1,397.43% |
API Access
Denali Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();